• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在存在异质性和自我选择情况下使用工具变量:乳腺癌患者治疗的应用

Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients.

作者信息

Basu Anirban, Heckman James J, Navarro-Lozano Salvador, Urzua Sergio

机构信息

Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

出版信息

Health Econ. 2007 Nov;16(11):1133-57. doi: 10.1002/hec.1291.

DOI:10.1002/hec.1291
PMID:17910109
Abstract

Instrumental variable (IV) methods are widely used in the health economics literature to adjust for hidden selection biases in observational studies when estimating treatment effects. Less attention has been paid in the applied literature to the proper use of IVs if treatment effects are heterogeneous across subjects and individuals select treatments based on expected idiosyncratic gains or losses from treatments. In this paper we compare conventional IV analysis with alternative approaches that use IVs to estimate treatment effects in models with response heterogeneity and self-selection. Instead of interpreting IV estimates as the effect of treatment at an unknown margin of patients, we identify the marginal patients and we apply the method of local IVs to estimate the average treatment effect and the effect on the treated on 5-year direct costs of breast-conserving surgery and radiation therapy compared with mastectomy in breast cancer patients. We use a sample from the Outcomes and Preferences in Older Women, Nationwide Survey which is designed to be representative of all female Medicare beneficiaries (aged 67 or older) with newly diagnosed breast cancer between 1992 and 1994. Our results reveal some of the advantages and limitations of conventional and alternative IV methods in estimating mean treatment effect parameters.

摘要

在估计治疗效果时,工具变量(IV)方法在健康经济学文献中被广泛用于调整观察性研究中隐藏的选择偏差。如果治疗效果在不同个体之间存在异质性,且个体根据治疗预期的特殊收益或损失来选择治疗方法,那么应用文献中对工具变量的正确使用关注较少。在本文中,我们将传统的IV分析与使用IV来估计具有反应异质性和自我选择模型中治疗效果的替代方法进行比较。我们不是将IV估计值解释为在未知患者边际上的治疗效果,而是识别边际患者,并应用局部IV方法来估计平均治疗效果以及乳腺癌患者保乳手术和放射治疗与乳房切除术相比对5年直接成本的治疗效果。我们使用了来自“老年女性结局与偏好全国性调查”的样本,该调查旨在代表1992年至1994年间所有新诊断为乳腺癌的女性医疗保险受益人(年龄67岁及以上)。我们的结果揭示了传统IV方法和替代IV方法在估计平均治疗效果参数方面的一些优点和局限性。

相似文献

1
Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients.在存在异质性和自我选择情况下使用工具变量:乳腺癌患者治疗的应用
Health Econ. 2007 Nov;16(11):1133-57. doi: 10.1002/hec.1291.
2
An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.对医疗保险人群中局部乳腺癌治疗结果的探索性工具变量分析。
Health Econ. 2003 Mar;12(3):171-86. doi: 10.1002/hec.710.
3
Heterogeneity and the interpretation of treatment effect estimates from risk adjustment and instrumental variable methods.风险调整和工具变量方法中治疗效果估计值的异质性及解释
Med Care. 2007 Oct;45(10 Supl 2):S123-30. doi: 10.1097/MLR.0b013e318070c069.
4
Assessment of the current Medicare reimbursement system for breast cancer operations.对当前医疗保险中乳腺癌手术报销系统的评估。
Ann Surg Oncol. 2004 Dec;11(12):1037-44. doi: 10.1245/ASO.2004.03.034. Epub 2004 Nov 15.
5
Estimating Decision-Relevant Comparative Effects Using Instrumental Variables.使用工具变量估计决策相关的比较效应。
Stat Biosci. 2011 Sep;3(1):6-27. doi: 10.1007/s12561-011-9033-6.
6
Mortality impact of less-than-standard therapy in older breast cancer patients.老年乳腺癌患者接受低于标准治疗的死亡率影响
J Am Coll Surg. 2008 Jan;206(1):66-75. doi: 10.1016/j.jamcollsurg.2007.07.015. Epub 2007 Oct 3.
7
Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.估计结直肠癌患者护理发病成本方法的比较。
Med Care. 2009 Jul;47(7 Suppl 1):S56-63. doi: 10.1097/MLR.0b013e3181a4f482.
8
Treatment variation by insurance status for breast cancer patients.乳腺癌患者因保险状况导致的治疗差异。
Breast J. 2008 Mar-Apr;14(2):128-34. doi: 10.1111/j.1524-4741.2007.00542.x.
9
Cost of care for elderly cancer patients in the United States.美国老年癌症患者的护理费用。
J Natl Cancer Inst. 2008 May 7;100(9):630-41. doi: 10.1093/jnci/djn103. Epub 2008 Apr 29.
10
Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.乳腺癌女性患者的外科医生特征与辅助放疗的接受情况
J Natl Cancer Inst. 2008 Feb 6;100(3):199-206. doi: 10.1093/jnci/djm320. Epub 2008 Jan 29.

引用本文的文献

1
Surgery or radiotherapy for early-stage cancer study (SORT) target trial protocol: stereotactic ablative radiotherapy (SABR) with curative intent versus surgical resection for early-stage non-small cell lung cancer (NSCLC).早期癌症手术或放疗研究(SORT)目标试验方案:根治性立体定向消融放疗(SABR)与早期非小细胞肺癌(NSCLC)手术切除的对比
BMJ Open. 2025 Jul 13;15(7):e103038. doi: 10.1136/bmjopen-2025-103038.
2
An Approach for Combining Clinical Judgment with Machine Learning to Inform Medical Decision Making: Analysis of Nonemergency Surgery Strategies for Acute Appendicitis in Patients with Multiple Long-Term Conditions.一种结合临床判断与机器学习以辅助医疗决策的方法:对伴有多种长期疾病的急性阑尾炎患者的非紧急手术策略的分析。
Med Decis Making. 2024 Nov;44(8):944-960. doi: 10.1177/0272989X241289336. Epub 2024 Oct 23.
3
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations.超越随机对照试验,评估不同目标人群的治疗效果异质性。
Health Econ. 2025 Jan;34(1):85-104. doi: 10.1002/hec.4903. Epub 2024 Sep 26.
4
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature.解决经济评价中患者异质性问题的进展:方法文献综述。
Pharmacoeconomics. 2024 Jul;42(7):737-749. doi: 10.1007/s40273-024-01377-9. Epub 2024 Apr 27.
5
Assessing the properties of patient-specific treatment effect estimates from causal forest algorithms under essential heterogeneity.评估因果森林算法在本质异质性下对特定于患者的治疗效果估计的特性。
BMC Med Res Methodol. 2024 Mar 13;24(1):66. doi: 10.1186/s12874-024-02187-5.
6
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low-income adults.工具变量分析在成本结果中的应用:在低收入成年人中,初级保健就诊对医疗费用的影响。
Stat Med. 2023 Oct 30;42(24):4349-4376. doi: 10.1002/sim.9865. Epub 2023 Aug 7.
7
How does a local instrumental variable method perform across settings with instruments of differing strengths? A simulation study and an evaluation of emergency surgery.局部工具变量方法在具有不同强度工具的设置中表现如何?一项模拟研究和对急诊手术的评估。
Health Econ. 2023 Sep;32(9):2113-2126. doi: 10.1002/hec.4719. Epub 2023 Jun 11.
8
Remission and Relapse of Dyslipidemia After Vertical Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass in a Racially and Ethnically Diverse Population.在一个种族和民族多样化的人群中,垂直袖状胃切除术与 Roux-en-Y 胃旁路手术后血脂异常的缓解和复发。
JAMA Netw Open. 2022 Sep 1;5(9):e2233843. doi: 10.1001/jamanetworkopen.2022.33843.
9
Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose?高风险医疗器械卫生技术评估中的真实世界证据:是否适用?
Health Econ. 2022 Sep;31 Suppl 1(Suppl 1):10-24. doi: 10.1002/hec.4575. Epub 2022 Aug 21.
10
Assessing the ability of an instrumental variable causal forest algorithm to personalize treatment evidence using observational data: the case of early surgery for shoulder fracture.评估工具变量因果森林算法利用观察数据进行个体化治疗证据的能力:以肩部骨折早期手术为例。
BMC Med Res Methodol. 2022 Jul 11;22(1):190. doi: 10.1186/s12874-022-01663-0.